Contrast-enhanced ultrasound (CEUS) in the evaluation of bladder pathologies: Review

Saubhagya Srivastava , Daniel Van Roekel , Jonathan L. Wright , Matthew Bruce , Manjiri Dighe
{"title":"Contrast-enhanced ultrasound (CEUS) in the evaluation of bladder pathologies: Review","authors":"Saubhagya Srivastava ,&nbsp;Daniel Van Roekel ,&nbsp;Jonathan L. Wright ,&nbsp;Matthew Bruce ,&nbsp;Manjiri Dighe","doi":"10.1016/j.wfumbo.2023.100019","DOIUrl":null,"url":null,"abstract":"<div><p>Contrast-enhanced Ultrasound (CEUS) is an advanced ultrasound (US) technique that utilizes specific US contrast agents (UCAs) to provide a more detailed evaluation of anatomic structures and parenchymal vasculature. Although the use of CEUS has been well-established in echocardiography and imaging of focal liver lesions, the updated guidelines by WFUMB-EFSUMB from 2018 also talk about the use of CEUS in the urinary bladder under non-hepatic applications of CEUS. The most common application of CEUS in the urinary bladder is the differentiation between bladder cancer and benign lesions such as a hematoma in patients presenting with hematuria. CEUS is also a promising imaging modality that can be used to detect and stage bladder urothelial cancers. CEUS greatly improves the diagnostic accuracy of conventional US techniques in the detection of bladder cancer. It has been shown previously that low- and high-grade bladder cancers tend to behave differently on the time-intensity curves (TIC) of CEUS. Low-grade bladder cancers tend to show a TIC with an early peak enhancement with a slow plateau and a longer time taken for contrast disappearance, whereas high-grade bladder cancers tend to show a rapid and high peak enhancement with rapid contrast disappearance (fast wash-out phase). In patients presenting with hematuria, CEUS accurately differentiates the etiology as either malignant or benign (i.e., hematoma) as hematomas are non-vascular lesions and do not show any enhancement as opposed to bladder cancers which tend to be highly vascular. CEUS holds several advantages such as being widely available, quick, and cost-efficient. CEUS is also suitable for patients who have contraindications to undergo CT, MRI, and/or conventional cystoscopy. Additionally, CEUS can be safely performed in patients with renal failure as UCAs are not nephrotoxic and not deposited in tissues as they are blood pool agents and are metabolized and excreted via pulmonary breathing.</p></div>","PeriodicalId":101281,"journal":{"name":"WFUMB Ultrasound Open","volume":"1 2","pages":"Article 100019"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"WFUMB Ultrasound Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949668323000198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Contrast-enhanced Ultrasound (CEUS) is an advanced ultrasound (US) technique that utilizes specific US contrast agents (UCAs) to provide a more detailed evaluation of anatomic structures and parenchymal vasculature. Although the use of CEUS has been well-established in echocardiography and imaging of focal liver lesions, the updated guidelines by WFUMB-EFSUMB from 2018 also talk about the use of CEUS in the urinary bladder under non-hepatic applications of CEUS. The most common application of CEUS in the urinary bladder is the differentiation between bladder cancer and benign lesions such as a hematoma in patients presenting with hematuria. CEUS is also a promising imaging modality that can be used to detect and stage bladder urothelial cancers. CEUS greatly improves the diagnostic accuracy of conventional US techniques in the detection of bladder cancer. It has been shown previously that low- and high-grade bladder cancers tend to behave differently on the time-intensity curves (TIC) of CEUS. Low-grade bladder cancers tend to show a TIC with an early peak enhancement with a slow plateau and a longer time taken for contrast disappearance, whereas high-grade bladder cancers tend to show a rapid and high peak enhancement with rapid contrast disappearance (fast wash-out phase). In patients presenting with hematuria, CEUS accurately differentiates the etiology as either malignant or benign (i.e., hematoma) as hematomas are non-vascular lesions and do not show any enhancement as opposed to bladder cancers which tend to be highly vascular. CEUS holds several advantages such as being widely available, quick, and cost-efficient. CEUS is also suitable for patients who have contraindications to undergo CT, MRI, and/or conventional cystoscopy. Additionally, CEUS can be safely performed in patients with renal failure as UCAs are not nephrotoxic and not deposited in tissues as they are blood pool agents and are metabolized and excreted via pulmonary breathing.

对比增强超声(CEUS)在膀胱病理评估中的应用综述
造影增强超声(CEUS)是一种先进的超声技术,利用特定的超声造影剂(UCA)对解剖结构和实质血管系统进行更详细的评估。尽管CEUS在肝局灶性病变的超声心动图和成像中的应用已经得到了证实,但WFUMB-EFSUMB从2018年起更新的指南也谈到了在非肝应用CEUS的情况下在膀胱中使用CEUS。CEUS在膀胱中最常见的应用是鉴别伴有血尿的患者的膀胱癌症和良性病变(如血肿)。CEUS也是一种很有前途的成像方式,可用于检测和分期膀胱尿路上皮癌。CEUS极大地提高了传统US技术在检测癌症中的诊断准确性。先前已经表明,低级别和高级别膀胱癌在CEUS的时间-强度曲线(TIC)上的表现往往不同。低级别膀胱癌倾向于显示TIC,早期峰值增强,具有缓慢的平台期和较长的对比度消失时间,而高级别膀胱癌趋向于显示快速和高峰值增强,对比度快速消失(快速冲洗期)。在出现血尿的患者中,CEUS准确地将病因区分为恶性或良性(即血肿),因为血肿是非血管性病变,与倾向于高度血管性的膀胱癌相比,没有表现出任何增强。CEUS具有多种优势,如广泛可用、快速和成本效益。CEUS也适用于有CT、MRI和/或常规膀胱镜检查禁忌症的患者。此外,肾功能衰竭患者可以安全地进行CEUS,因为UCA没有肾毒性,也不会沉积在组织中,因为它们是血库剂,通过肺呼吸代谢和排泄。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信